Hyperfine, Inc. Class A (HYPR) Dividend History

Company News

• Hyperfine (HYPR) to Release ACTION PMR Study Data for Swoop - Zacks Investment Research

  Hyperfine's Swoop system has shown promising results in a study on its ability to quickly assess stroke patients and guide treatment decisions. The study, part of the larger ACTION PMR study, found the Swoop system to be a reliable tool for enabling critical stroke treatment choices in urgent care settings.

  Zacks Investment Research

  Featured Companies: AZTA HAE HIMS
• Why You Should Bet on 5 Top-Ranked Stocks With Rising P/E

  Tap five stocks with increasing P/E ratios to try out an out-of-the-box approach. These are Vita Coco Company (COCO), AMC Entertainment (AMC), Hyperfine (HYPR), Aptevo Therapeutics (APVO) and CLEAR Secure (YOU).

  Zacks Investment Research

  Featured Companies: AMC APVO COCO YOU
• Hyperfine, Inc. (HYPR) Reports Q1 Loss, Tops Revenue Estimates

  Hyperfine (HYPR) delivered earnings and revenue surprises of 0% and 8.75%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?

  Zacks Investment Research
• Hyperfine, Inc. Reports First Quarter 2024 Financial Results

  GUILFORD, Conn., May 13, 2024 (GLOBE NEWSWIRE) -- Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking health technology company that has redefined brain imaging with the first FDA-cleared portable magnetic resonance (MR) brain imaging system—the Swoop® system—today announced first quarter 2024 financial results and provided a business update.

  GlobeNewswire Inc.
• Will Hyperfine, Inc. (HYPR) Report Negative Earnings Next Week? What You Should Know

  Hyperfine (HYPR) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

  Zacks Investment Research

  Featured Companies: LFWD